Globe Newswire
- Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis (NCT06207370) to be disclosed on October 6, 2026.
- Key Opinion Leader investor webinar scheduled for October 6, 2026, featuring leading babesiosis experts Dr. Peter Krause and Dr. Edouard Vannier.
WASHINGTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company that develops and... (continue reading...)
Paris, October 1st 2026, 2:00 p.m.
PRESS RELEASE
Eramet plans to apply under Argentina’s Large Investment Incentive Regime (RIGI) for a first expansion of Centenario-Ratones
- Eramet reaffirms its long-term commitment to Argentina with potential additional investment of around US$350 million in Centenario-Ratones, subject to final investment decision
- Completion of the Pre-Feasibility Study for an initial brownfield expansion, adding 11 kt-LCE per year to the existing... (continue reading...)
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The United Steelworkers union (USW) welcomes Prime Minister Mark Carney’s commitment to hold Cleveland-Cliffs accountable for its legal obligations to Canadian workers and is calling on the federal government to follow through with action to protect jobs and Canada’s steelmaking capacity.
Cleveland-Cliffs has announced the indefinite idling of steelmaker Stelco’s cold-rolled and coated operations in Hamilton, where roughly... (continue reading...)
VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) today announced the acquisition of John F Hunt Power Group Limited (“John F Hunt Power”).John F Hunt Power is one of the UK’s larger specialist generator rental companies, with a strong industry brand built on delivering high-quality solutions and service, and a track record of profitable growth. John F Hunt Power... (continue reading...)
- SpyGlass Pharma acquires 100% of the outstanding shares of AVS, a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), the existing manufacturer of SpyGlass Pharma’s intraocular lens (IOL)
- Secures scalable commercial IOL manufacturing capacity for its Phase 3 lead product candidate, the BIM-IOL System
- Accelerates pathway to adding premium lens options into its IOL-based drug delivery system
- SpyGlass Pharma intends to continue supporting AVS customers and licensees... (continue reading...)
More Globe Newswire
View Older Stories-
TopNod Wallet Debuts Access to Axil’s APT (Axil Pot), a T+0 On-Chain Yield Product for Everyday Idle Liquidity
-
Global-e Appoints Tomer Gold as Chief Revenue Officer
-
Form 8.3 - Vesuvius Plc
-
South Star Hosts Harvard Students for Potential AI Use at Santa Cruz
-
Teal Lights and Shared Stories: The Facial Pain Association Marks Facial Pain Awareness Month This October
-
From Movie Sets to Experimental Games: Meet the Craftspeople Shaping Genshin Impact's Miliastra Wonderland
-
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A
-
SONORO GOLD ANNOUNCES CONTINUED EXPANSION OF HIGHER-GRADE MINERALIZATION AT CERRO CALICHE
-
ViCentra Presents Large-Scale Real-World Evidence Demonstrating Kaleido Insulin Patch Pump System Delivers Stable Glucose Control with Very Low Hypoglycemia
-
Canada’s changing workforce calls for a broader approach to talent
-
Carpenter Technology Announces Conference Call and Webcast
-
Taiwan Excellence Builds Taiwan-U.S. Connections Through Innovation and Culture at Taiwan Expo USA 2026
-
Sophos Launches CISO Advantage, Bringing CISO-Level Security Strategy Within Reach of Every Organization
-
Lands' End Announces Participation in the 2026 Global Consumer & Retail Conference
-
HealthLynked Selects DRCARE247 as Telemedicine Partner to Expand Integrated Virtual Care Platform
-
Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
-
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
-
HydroGraph to Showcase Fractal Graphene Paste™ at The Advanced Materials Show USA
-
Company Culture Is Critical to Getting Business Value from AI
-
SolSource Closes $300 Million of New Financing to Enable Geographic Expansion
-
Next Technology Holding Inc. Announces US$35 Million R&D Initiative Across AI-Integrated SaaS, AI Computing, and Robotics
-
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
-
Crypto News: Remittix Reveals RTX Launch Date as Bitcoin Price Prediction Tracks Citi’s $113,000 Target and Quant Secures Clearing House Deal
-
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
-
Genius Group CEO Roger Hamilton Buys 1,000,000 Company Shares on the Open Market
-
Next Technology Holding Inc. Announces US$35 Million R&D Initiative Across AI-Integrated SaaS, AI Computing, and Robotics
-
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Str
-
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
-
NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets
-
Powerus Completes Merger with Aureus Greenway Holdings; Powerus Corporation to Ring Nasdaq Opening Bell, Trading as PUSA
-
Namib Minerals Reports First-Half 2026 Financial Results and Provides Business Update
-
Apollo Expands Daily Pricing to All Credit Assets, Advancing Transparency in Private Credit
-
Gentex Schedules Third Quarter 2026 Earnings Release Date and Conference Call
-
Lands' End Announces Participation in the 2026 Global Consumer & Retail Conference
-
Veea Announces TROLLEE Agreement for Phased Deployment of VeeaONE to 1,000 Unattended Stores
-
Aptera Significantly Reduces Estimated Capital Requirements for Production
-
Charleys Cheesesteaks Turns Up the Heat on Cold Subs With New Menu, Rewards Program and Brand Campaign
-
Linkhome Holdings Launches GPU Marketplace 2.0 to Expand Access to On-Demand AI Compute
-
Deep Isolation Advances Nuclear Waste Disposal Demonstration With Issuance of Texas Drilling Permit
-
EquityProtect Q3 2026 Property Protection Scorecard: 12 States Now Have Deed Theft Laws, but Most Homeowner Protections Still Work Only After Fraud Occurs
-
Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors
-
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
-
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
-
From Movie Sets to Experimental Games: Meet the Craftspeople Shaping Genshin Impact's Miliastra Wonderland
-
Balt Announces First Patients Enrolled in Silk Vista Baby™ PIONEER Study
-
Capitolis Wins 2026 GlobalCapital Derivatives Awards for Optimization Service of the Year – Americas, Europe, and Asia
-
Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended September 30, 2026
-
EMIAH M7 Fall Preview: Powered Adjustment for Everyday Home Comfort
-
Ateios Brings 50-MWh Electrode Coating Line Online, Ships Next-Gen RaiCore® Electrodes

